207 related articles for article (PubMed ID: 29577937)
21. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
[TBL] [Abstract][Full Text] [Related]
22. CD81 suppresses NF-κB signaling and is downregulated in hepatitis C virus expressing cells.
Bunz M; Eisele M; Hu D; Ritter M; Kammerloher J; Lampl S; Schindler M
Front Cell Infect Microbiol; 2024; 14():1338606. PubMed ID: 38357447
[TBL] [Abstract][Full Text] [Related]
23. Glypican-3-mediated oncogenesis involves the Insulin-like growth factor-signaling pathway.
Cheng W; Tseng CJ; Lin TT; Cheng I; Pan HW; Hsu HC; Lee YM
Carcinogenesis; 2008 Jul; 29(7):1319-26. PubMed ID: 18413366
[TBL] [Abstract][Full Text] [Related]
24. Cellular changes resulting from forced expression of glypican-3 in hepatocellular carcinoma cells.
Kwack MH; Choi BY; Sung YK
Mol Cells; 2006 Apr; 21(2):224-8. PubMed ID: 16682817
[TBL] [Abstract][Full Text] [Related]
25. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma.
Luan F; Liu P; Ma H; Yue X; Liu J; Gao L; Liang X; Ma C
Int J Biochem Cell Biol; 2014 Oct; 55():129-35. PubMed ID: 25195714
[TBL] [Abstract][Full Text] [Related]
26. JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
Ye J; Li TS; Xu G; Zhao YM; Zhang NP; Fan J; Wu J
Cancer Res; 2017 Oct; 77(19):5287-5300. PubMed ID: 28775168
[TBL] [Abstract][Full Text] [Related]
27. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
28. Impaired autophagy response in human hepatocellular carcinoma.
Bao L; Chandra PK; Moroz K; Zhang X; Thung SN; Wu T; Dash S
Exp Mol Pathol; 2014 Apr; 96(2):149-54. PubMed ID: 24369267
[TBL] [Abstract][Full Text] [Related]
29. Viral factors induce Hedgehog pathway activation in humans with viral hepatitis, cirrhosis, and hepatocellular carcinoma.
Pereira Tde A; Witek RP; Syn WK; Choi SS; Bradrick S; Karaca GF; Agboola KM; Jung Y; Omenetti A; Moylan CA; Yang L; Fernandez-Zapico ME; Jhaveri R; Shah VH; Pereira FE; Diehl AM
Lab Invest; 2010 Dec; 90(12):1690-703. PubMed ID: 20697376
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
31. CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes.
Brazzoli M; Bianchi A; Filippini S; Weiner A; Zhu Q; Pizza M; Crotta S
J Virol; 2008 Sep; 82(17):8316-29. PubMed ID: 18579606
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus infection propagates through interactions between Syndecan-1 and CD81 and impacts the hepatocyte glycocalyx.
Grigorov B; Reungoat E; Gentil Dit Maurin A; Varbanov M; Blaising J; Michelet M; Manuel R; Parent R; Bartosch B; Zoulim F; Ruggiero F; Pécheur EI
Cell Microbiol; 2017 May; 19(5):. PubMed ID: 27930836
[TBL] [Abstract][Full Text] [Related]
33. Generation of infectious HCV pseudo typed particles and its utilization for studying the role of CD81 & SRBI receptors in HCV infection.
Rafique S; Idrees M; Ali A; Sahibzada KI; Iqbal M
Mol Biol Rep; 2014 Jun; 41(6):3813-9. PubMed ID: 24549717
[TBL] [Abstract][Full Text] [Related]
34. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte-targeted glypican 3 transgenic mice.
Liu B; Bell AW; Paranjpe S; Bowen WC; Khillan JS; Luo JH; Mars WM; Michalopoulos GK
Hepatology; 2010 Sep; 52(3):1060-7. PubMed ID: 20812357
[TBL] [Abstract][Full Text] [Related]
35. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver.
Young KC; Lin PW; Hsiao WC; Chang TT; Chang YC; Wu HL
J Med Virol; 2002 Oct; 68(2):188-96. PubMed ID: 12210407
[TBL] [Abstract][Full Text] [Related]
36. Epigallocatechin gallate (EGCG) and miR-548m reduce HCV entry through repression of CD81 receptor in HCV cell models.
Mekky RY; El-Ekiaby N; El Sobky SA; Elemam NM; Youness RA; El-Sayed M; Hamza MT; Esmat G; Abdelaziz AI
Arch Virol; 2019 Jun; 164(6):1587-1595. PubMed ID: 30949812
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
38. The osteopontin-CD44 axis in hepatic cancer stem cells regulates IFN signaling and HCV replication.
Shirasaki T; Honda M; Yamashita T; Nio K; Shimakami T; Shimizu R; Nakasyo S; Murai K; Shirasaki N; Okada H; Sakai Y; Sato T; Suzuki T; Yoshioka K; Kaneko S
Sci Rep; 2018 Sep; 8(1):13143. PubMed ID: 30177680
[TBL] [Abstract][Full Text] [Related]
39. Liver stem cells: implications for hepatocarcinogenesis.
Alison MR
Stem Cell Rev; 2005; 1(3):253-60. PubMed ID: 17142862
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3.
Zhu XT; Yuan JH; Zhu TT; Li YY; Cheng XY
FEBS J; 2016 Oct; 283(20):3739-3754. PubMed ID: 27573079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
